These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26930141)

  • 1. Exploiting the antivirulence efficacy of an ajoene-ciprofloxacin combination against Pseudomonas aeruginosa biofilm associated murine acute pyelonephritis.
    Vadekeetil A; Saini H; Chhibber S; Harjai K
    Biofouling; 2016; 32(4):371-82. PubMed ID: 26930141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin and ciprofloxacin: a possible synergistic combination against Pseudomonas aeruginosa biofilm-associated urinary tract infections.
    Saini H; Chhibber S; Harjai K
    Int J Antimicrob Agents; 2015 Apr; 45(4):359-67. PubMed ID: 25604277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant effect of cranberry proanthocyanidin active fraction on antivirulent property of ciprofloxacin against Pseudomonas aeruginosa.
    Vadekeetil A; Alexandar V; Chhibber S; Harjai K
    Microb Pathog; 2016 Jan; 90():98-103. PubMed ID: 26620081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Azithromycin-Ciprofloxacin-Impregnated Urinary Catheters Avert Bacterial Colonization, Biofilm Formation, and Inflammation in a Murine Model of Foreign-Body-Associated Urinary Tract Infections Caused by Pseudomonas aeruginosa.
    Saini H; Vadekeetil A; Chhibber S; Harjai K
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28031194
    [No Abstract]   [Full Text] [Related]  

  • 5. Synergistic activity of sub-inhibitory concentrations of curcumin with ceftazidime and ciprofloxacin against Pseudomonas aeruginosa quorum sensing related genes and virulence traits.
    Roudashti S; Zeighami H; Mirshahabi H; Bahari S; Soltani A; Haghi F
    World J Microbiol Biotechnol; 2017 Mar; 33(3):50. PubMed ID: 28188589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravesical targeting of novel quorum sensing inhibitor nanoparticles against
    Vadekeetil A; Chhibber S; Harjai K
    J Drug Target; 2019 Nov; 27(9):995-1003. PubMed ID: 30741037
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of Ciprofloxacin and Its Copper Complex against Pseudomonas aeruginosa Biofilms.
    Tewes F; Bahamondez-Canas TF; Smyth HDC
    AAPS PharmSciTech; 2019 May; 20(5):205. PubMed ID: 31144198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ciprofloxacin-eluting nanofibers inhibits biofilm formation by Pseudomonas aeruginosa and a methicillin-resistant Staphylococcus aureus.
    Ahire JJ; Neveling DP; Hattingh M; Dicks LM
    PLoS One; 2015; 10(4):e0123648. PubMed ID: 25853255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of ciprofloxacin-clarithromycin combination against drug-resistant Pseudomonas aeruginosa mature biofilm using in vitro experimental model.
    Elkhatib W; Noreddin A
    Microb Drug Resist; 2014 Dec; 20(6):575-82. PubMed ID: 25050970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Real-Time Monitoring of
    Zaborskyte G; Andersen JB; Kragh KN; Ciofu O
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 27993856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of the Major Multifunctional Catalase KatA in Pseudomonas aeruginosa Accelerates Evolution of Antibiotic Resistance in Ciprofloxacin-Treated Biofilms.
    Ahmed MN; Porse A; Abdelsamad A; Sommer M; Høiby N; Ciofu O
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31307984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitigation of a nitrate reducing Pseudomonas aeruginosa biofilm and anaerobic biocorrosion using ciprofloxacin enhanced by D-tyrosine.
    Jia R; Yang D; Xu D; Gu T
    Sci Rep; 2017 Jul; 7(1):6946. PubMed ID: 28761161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-acetylcysteine inhibit biofilms produced by Pseudomonas aeruginosa.
    Zhao T; Liu Y
    BMC Microbiol; 2010 May; 10():140. PubMed ID: 20462423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incorporation of Farnesol Significantly Increases the Efficacy of Liposomal Ciprofloxacin against Pseudomonas aeruginosa Biofilms in Vitro.
    Bandara HM; Herpin MJ; Kolacny D; Harb A; Romanovicz D; Smyth HD
    Mol Pharm; 2016 Aug; 13(8):2760-70. PubMed ID: 27383205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of immunomodulatory S100A8/A9 and ciprofloxacin against Pseudomonas aeruginosa biofilm in a murine chronic wound model.
    Laulund ASB; Trøstrup H; Lerche CJ; Thomsen K; Christophersen L; Calum H; Høiby N; Moser C
    Pathog Dis; 2020 Jul; 78(5):. PubMed ID: 31116394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of ABT-719, a 2-pyridone antimicrobial, against enterococci, Escherichia coli, and Pseudomonas aeruginosa in experimental murine pyelonephritis.
    Meulbroek JA; Oleksijew A; Tanaka SK; Alder JD
    J Antimicrob Chemother; 1996 Oct; 38(4):641-53. PubMed ID: 8937959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of the sub-minimal inhibitory concentration and the concentrations within resistant mutation window of ciprofloxacin on MIC, swimming motility and biofilm formation of Pseudomonas aeruginosa.
    Shi N; Gao Y; Yin D; Song Y; Kang J; Li X; Zhang Z; Feng X; Duan J
    Microb Pathog; 2019 Dec; 137():103765. PubMed ID: 31586475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formation of hydroxyl radicals contributes to the bactericidal activity of ciprofloxacin against Pseudomonas aeruginosa biofilms.
    Jensen PØ; Briales A; Brochmann RP; Wang H; Kragh KN; Kolpen M; Hempel C; Bjarnsholt T; Høiby N; Ciofu O
    Pathog Dis; 2014 Apr; 70(3):440-3. PubMed ID: 24376174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo activity of EDTA and antibacterial agents against the biofilm of mucoid Pseudomonas aeruginosa.
    Liu Z; Lin Y; Lu Q; Li F; Yu J; Wang Z; He Y; Song C
    Infection; 2017 Feb; 45(1):23-31. PubMed ID: 27189338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin.
    Garo E; Eldridge GR; Goering MG; DeLancey Pulcini E; Hamilton MA; Costerton JW; James GA
    Antimicrob Agents Chemother; 2007 May; 51(5):1813-7. PubMed ID: 17353241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.